Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Allysonne Smith"'
Autor:
Daniel Seung Kim, Emily L. Chu, Emily E. Keamy-Minor, Ishan Dhananjay Paranjpe, Wilson L. Tang, Jack W. O’Sullivan, Yaanik B. Desai, Michael B. Liu, Elise Munsey, Kimberly Hecker, Isabella Cuenco, Beth Kao, Ellen Bacolor, Colleen Bonnett, Andrea Linder, Kathleen Lacar, Nancy Robles, Cindy Lamendola, Allysonne Smith, Joshua W. Knowles, Marco V. Perez, Masataka Kawana, Karim I. Sallam, Chad S. Weldy, Matthew T. Wheeler, Victoria N. Parikh, Heidi Salisbury, Euan A. Ashley, the Stanford Center for Inherited Cardiovascular Disease, Karim I Sallam, Chad S Weldy, Marco Perez, Joshua W Knowles, Jason Tso, Julia Platt, Chloe Reuter, Tia Moscarello, Ryan Murtha, Jennifer Kohler, Hannah Ison, Mitchel Pariani, Anusha Klinder, Priya Nair, Jennifer Marino, Ruchi Patel, Matthew T Wheeler, Euan A Ashley, Victoria N Parikh
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Mavacamten is a first-in-class cardiac myosin ATPase inhibitor, approved by the United States Food and Drug Administration for the treatment of hypertrophic cardiomyopathy with obstructive physiology (oHCM). Here, we present the real-world use of mav
Externí odkaz:
https://doaj.org/article/10cfc802d1ec46fb9a4e39b0fd818be9
Autor:
William R. Goodyer, Chloe M. Reuter, Tia Moscarello, Jennifer Wylie, Euan A. Ashley, Kyla Dunn, Marco V Perez, Allysonne Smith, Julia Platt, Phillip C. Yang, Kara S. Motonaga, Anne M. Dubin, Colleen Caleshu, Scott R. Ceresnak, Anthony Trela, Mary Jackson
Publikováno v:
Circulation. Genomic and precision medicine. 12(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10348e9d7ae093551c78a7e10e740b6f
https://pubmed.ncbi.nlm.nih.gov/31638414
https://pubmed.ncbi.nlm.nih.gov/31638414